Biotech · Private company
Shield Therapeutics
Track this companyFree. Adds Shield Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Ferric Carboxy MaltosePhase 3 · Anemia, Iron-DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Ferric maltolPhase 3 · Renal Insufficiency, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- Ferric MaltolPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Ferric MaltolPhase 3 · Anemia, Iron-DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Ferrous sulfatePhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Ferric maltol capsulePhase 1 · Anemia, Iron DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Ferric maltol suspensionPhase 1 · Anemia, Iron DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 YearsPHASE3 · COMPLETED · started Nov 3, 2021ClinicalTrials.gov NCT05126901 · fetched Nov 12, 2026
- Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy VolunteersPHASE1 · COMPLETED · started Sep 28, 2020ClinicalTrials.gov NCT04626414 · fetched Nov 12, 2026
- Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney DiseasePHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02968368 · fetched Nov 12, 2026
- Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBDPHASE3 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02680756 · fetched Nov 12, 2026